LIPO (Lipella Pharmaceuticals) Total Stockholders Equity: $1.49 Mil (As of Sep. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Lipella Pharmaceuticals Total Stockholders Equity?

Lipella Pharmaceuticals LIPO -49.38% Total Stockholders Equity is $1.49 Mil as of Sep. 2025. The stock has 1 warning sign investors should review.

Lipella Pharmaceuticals's Total Stockholders Equity for the quarter that ended in Sep. 2025 was $1.49 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Lipella Pharmaceuticals's Book Value per Share for the quarter that ended in Sep. 2025 was $0.32. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Lipella Pharmaceuticals's Debt-to-Equity for the quarter that ended in Sep. 2025 was 0.18.

Lipella Pharmaceuticals  (OTCPK:LIPO) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Lipella Pharmaceuticals's Book Value per Share for the quarter that ended in Sep. 2025 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(1.488-0)/4.621
=0.32

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Lipella Pharmaceuticals's Debt-to-Equity for the quarter that ended in Sep. 2025 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(0.044 + 0.22) / 1.488
=0.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lipella Pharmaceuticals Total Stockholders Equity Related Terms

Lipella Pharmaceuticals Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Lipella Pharmaceuticals's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lipella Pharmaceuticals Total Stockholders Equity Chart

Lipella Pharmaceuticals Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Total Stockholders Equity
0.46 1.42 4.68 3.14 1.92

Lipella Pharmaceuticals Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.46 1.92 4.08 2.74 1.49
What does a Total Stockholders Equity of $1.49 Mil mean?
Lipella Pharmaceuticals (LIPO) has a Total Stockholders Equity of $1.49 Mil as of Sep. 2025. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Lipella Pharmaceuticals and its competitors.
Is Lipella Pharmaceuticals' Total Stockholders Equity too high?
Lipella Pharmaceuticals' current Total Stockholders Equity is $1.49 Mil.
How does Lipella Pharmaceuticals' Total Stockholders Equity compare to SIGY and CNBX?
Lipella Pharmaceuticals' Total Stockholders Equity of $1.49 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Biotechnology company?
A good Total Stockholders Equity depends on the Biotechnology industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Lipella Pharmaceuticals and its competitors. Lipella Pharmaceuticals's current Total Stockholders Equity is $1.49 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lipella Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Lipella Pharmaceuticals (LIPO) is currently considered Possible Value Trap. The stock's GF Value™ is $8.76, compared to a current price of $0.03 — trading 99.6% below its estimated fair value. The current Total Stockholders Equity is $1.49 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For Lipella Pharmaceuticals (LIPO), the current Total Stockholders Equity is $1.49 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Lipella Pharmaceuticals Business Description

Address 7800 Susquehanna Street, Suite 505, Pittsburgh, PA, USA, 15208
Lipella Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. The company's product candidates include LP-10, LP-310 and LP-410, which can be helpful in the treatment of Hemorrahagic Cystitis, Oral Licen Planus and Oral Graft.